Literature DB >> 32952555

Corrigendum to "HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia".

Aida Vitkevičienė1, Giedrė Skiauterytė1, Andrius Žučenka2,3, Mindaugas Stoškus2, Eglė Gineikienė2, Veronika Borutinskaitė1, Laimonas Griškevičius2,3, Rūta Navakauskienė1.   

Abstract

[This corrects the article DOI: 10.1155/2019/6179573.].
Copyright © 2020 Aida Vitkevičienė et al.

Entities:  

Year:  2020        PMID： 32952555      PMCID： PMC7487093          DOI： 10.1155/2020/1834190

Source DB:  PubMed          Journal:  J Oncol        ISSN： 1687-8450            Impact factor:   4.375


In the article titled “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” [1], the last author was mistakenly linked to the second affiliation instead of the first. The corrected author list and affiliations are shown above.
  1 in total

1.  HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia.

Authors:  Aida Vitkevičienė; Giedrė Skiauterytė; Andrius Žučenka; Mindaugas Stoškus; Eglė Gineikienė; Veronika Borutinskaitė; Laimonas Griškevičius; Rūta Navakauskienė
Journal:  J Oncol       Date:  2019-07-18       Impact factor: 4.375
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.